Title:
低血糖症の治療用経鼻粉末製剤
Document Type and Number:
Japanese Patent JP6522144
Kind Code:
B2
Abstract:
The present invention provides a powder formulation containing glucagon or a glucagon analog for nasal administration, useful in the treatment of hypoglycemia, and in particular the treatment of severe hypoglycemia. The present invention also provides a method of making this powder formulation, and to devices and methods for using the powder formulation.
More Like This:
Inventors:
Mantry Pragada, Sancolumbie.
Pisch, Claude A.
Van Betz Brugge, Yo Yang Philip
Pisch, Claude A.
Van Betz Brugge, Yo Yang Philip
Application Number:
JP2017541993A
Publication Date:
May 29, 2019
Filing Date:
February 16, 2016
Export Citation:
Assignee:
Eli Lilly and Company
International Classes:
A61K38/26; A61K9/19; A61K47/12; A61K47/24; A61K47/40; A61M15/08; A61P3/08; A61P43/00
Domestic Patent References:
| JP3502920A |
Foreign References:
| WO1992016196A1 |
Other References:
Int J Pharm,1996年,Vol.132,p.189-194
Biochim Biophys Acta,1981年,Vol.642,p.296-312
Biochim Biophys Acta,1981年,Vol.642,p.296-312
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Saori Oga
Yasuhito Suzuki
Eiji Katayama
Norio Omori
Saori Oga
Yasuhito Suzuki